The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Open accessAbstract
In the majority of patients multiple sclerosis starts with a relapsing remitting disease (RRMS), which may at later times transform into secondary progressive disease (SPMS). In a minority of patients the relapsing remitting disease is skipped and the patients show progression from the onset (primary progressive MS, PPMS). Evidence obtained so far indicate major differences between RRMS and progressive MS, but no essential differences between SPMS and PPMS, with the exception of a lower incidence in the global load of focal white matter lesions and in particular in the presence of classical active plaques. We suggest that in MS patients two types of inflammation occur, which develop in parallel but partially independent from each other. The first is the focal bulk invasion of T- and B-lymphocytes with profound blood brain barrier leakage, which predominately affects the white matter and which gives rise to classical active demyelinated plaques. The other type of inflammation is a slow accumulation of T-cells and B-cells in the absence of major blood brain barrier damage in the connective tissue spaces of the brain, such as the meninges and the large perivascular Virchow Robin spaces, where they may form aggregates or in most severe cases structures in part resembling tertiary lymph follicles. This type of inflammation is associated with the formation of subpial demyelinated lesions in the cerebral and cerebellar cortex, with slow expansion of pre-existing lesions in the white matter and with diffuse neurodegeneration in the normal appearing white or grey matter. The first type of inflammation dominates in acute and relapsing MS. The second type of inflammation is already present in early stages of MS, but gradually increases with disease duration and patient age. CD8+ T-lymphocytes remain in the brain and spinal cord as tissue resident cells, which focally propagate neuroinflammation, when they re-encounter their cognate antigen. B-lymphocytes appear to propagate demyelination and neurodegeneration, most likely by producing soluble neurotoxic factors. Key open questions in MS research are the identification of the target antigen recognized by tissue resident CD8+ T-cells and B-cells and the molecular nature of the soluble inflammatory mediators, which trigger tissue damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
Defining the clinical course of multiple sclerosis: The 2013 revisions
Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000560 · Cited by 3,177
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., de Seze, J., Giovannoni, G., Hartung, H.-P., Hemmer, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606468 · Cited by 1,905 · cited 11×
“These inflammatory sites mainly contain CD8+ T-cells, a major component of CD20+ B-cells and a variable number of plasma cells and may in their most severe manifestations become organized in structures with features of tertiary lymph follicles (green dots).”
BackgroundInfluentialCortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Self-citationMultiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 1×
“In this situation PPMS could reflect the primary disease process of MS and the other courses (RRMS and SPMS) are those, modified by an inflammatory reaction (3).”
Backgroundvon Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citationMagliozzi, R., Howell, O., Vora, A., Serafini, B., Nicholas, R., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,443
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International Multiple Sclerosis Genetics Consortium (IMSGC) (2013) · Nature Genetics · doi:10.1038/ng.2770 · Cited by 1,386
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Self-citationPathological mechanisms in progressive multiple sclerosis
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,137
Self-citationInflammatory cortical demyelination in early multiple sclerosis.
Lucchinetti, C. F., Popescu, B. F. G., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., Brück, W., Parisi, J. E., Scheithauer, B. W., Giannini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100648 · Cited by 1,103
Self-citationTissue-Resident Memory T Cells
Schenkel, J. M., & Masopust, D. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.007 · Cited by 1,059 · cited 1×
“CD8 resident memory cells have originally been defined and functionally characterized in experimental models of virus induced disease (114, 115).”
BackgroundProgressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Self-citationBabbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
Self-citationMultiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Self-citationLymphoid neogenesis in chronic inflammatory diseases
Aloisi, F., & Pujol-Borrell, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1786 · Cited by 908
in cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0718-0 · Cited by 899
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain · doi:10.1093/brain/awr182 · Cited by 858
Remyelination is extensive in a subset of multiple sclerosis patients
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., Bruck, W., Lucchinetti, C., & Lassmann, H. (2006) · Brain · doi:10.1093/brain/awl217 · Cited by 807
Self-citationA Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747
Frischer, J. M., Weigand, S. D., Guo, Y., Kale, N., Parisi, J. E., Pirko, I., Mandrekar, J., Bramow, S., Metz, I., Brück, W., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24497 · Cited by 728
Self-citationAn updated histological classification system for multiple sclerosis lesions
Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1653-y · Cited by 692 · cited 1×
“They include classical active lesions with pronounced blood brain barrier injury, chronic active or slowly expanding lesions with a low degree of demyelinating activity at the lesion edge and no major blood brain barrier damage, inactive lesions and remyelinated shadow plaques (46, 68, 69).”
BackgroundSelf-citationLoss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684 · cited 3×
“(38); Fibrin and blood brain barrier injury: Hochmeister et al.”
BackgroundResultSelf-citationEvidence for a two-stage disability progression in multiple sclerosis
Leray, E., Yaouanq, J., Le Page, E., Coustans, M., Laplaud, D., Oger, J., & Edan, G. (2010) · Brain · doi:10.1093/brain/awq076 · Cited by 596
Machado-Santos, J., Saji, E., Tröscher, A. R., Paunovic, M., Liblau, R., Gabriely, G., Bien, C. G., Bauer, J., & Lassmann, H. (2018) · Brain · doi:10.1093/brain/awy151 · Cited by 548
Self-citationMultiple sclerosis: experimental models and reality
Lassmann, H., & Bradl, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1631-4 · Cited by 525
Self-citationBarro, C., Benkert, P., Disanto, G., Tsagkas, C., Amann, M., Naegelin, Y., Leppert, D., Gobbi, C., Granziera, C., Yaldizli, Ö., et al. (2018) · Brain · doi:10.1093/brain/awy154 · Cited by 517
Primary progressive multiple sclerosis
Thompson, A. (1997) · Brain · doi:10.1093/brain/120.6.1085 · Cited by 506
Major differences in the dynamics of primary and secondary progressive multiple sclerosis
Thompson, A. J., Kermode, A. G., Wicks, D., MacManus, D. G., Kendall, B. E., Kingsley, D. P. E., & McDonald, W. I. (1991) · Annals of Neurology · doi:10.1002/ana.410290111 · Cited by 486
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
Dal-Bianco, A., Grabner, G., Kronnerwetter, C., Weber, M., Höftberger, R., Berger, T., Auff, E., Leutmezer, F., Trattnig, S., Lassmann, H., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1636-z · Cited by 463
Self-citationTissue-resident memory T cells populate the human brain
Smolders, J., Heutinck, K. M., Fransen, N. L., Remmerswaal, E. B. M., Hombrink, P., ten Berge, I. J. M., van Lier, R. A. W., Huitinga, I., & Hamann, J. (2018) · Nature Communications · doi:10.1038/s41467-018-07053-9 · Cited by 406
Reassessing B cell contributions in multiple sclerosis
Li, R., Patterson, K. R., & Bar-Or, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0135-x · Cited by 401
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
Haider, L., Zrzavy, T., Hametner, S., Höftberger, R., Bagnato, F., Grabner, G., Trattnig, S., Pfeifenbring, S., Brück, W., & Lassmann, H. (2016) · Brain · doi:10.1093/brain/awv398 · Cited by 400
Self-citationMeningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Choi, S. R., Howell, O. W., Carassiti, D., Magliozzi, R., Gveric, D., Muraro, P. A., Nicholas, R., Roncaroli, F., & Reynolds, R. (2012) · Brain · doi:10.1093/brain/aws189 · Cited by 386
Cepok, S., Rosche, B., Grummel, V., Vogel, F., Zhou, D., Sayn, J., Sommer, N., Hartung, H.-P., & Hemmer, B. (2005) · Brain · doi:10.1093/brain/awh486 · Cited by 367
Haider, L., Simeonidou, C., Steinberger, G., Hametner, S., Grigoriadis, N., Deretzi, G., Kovacs, G. G., Kutzelnigg, A., Lassmann, H., & Frischer, J. M. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307712 · Cited by 357
Self-citationLuchetti, S., Fransen, N. L., van Eden, C. G., Ramaglia, V., Mason, M., & Huitinga, I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1818-y · Cited by 355
Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis
Kutzelnigg, A., Faber‐Rod, J. C., Bauer, J., Lucchinetti, C. F., Sorensen, P. S., Laursen, H., Stadelmann, C., Brück, W., Rauschka, H., Schmidbauer, M., et al. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00041.x · Cited by 336
Self-citationDemyelination versus remyelination in progressive multiple sclerosis
Bramow, S., Frischer, J. M., Lassmann, H., Koch-Henriksen, N., Lucchinetti, C. F., Sørensen, P. S., & Laursen, H. (2010) · Brain · doi:10.1093/brain/awq250 · Cited by 319
Self-citationRemyelination can be extensive in multiple sclerosis despite a long disease course
Patani, R., Balaratnam, M., Vora, A., & Reynolds, R. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00805.x · Cited by 318
Disease-specific molecular events in cortical multiple sclerosis lesions
Fischer, M. T., Wimmer, I., Höftberger, R., Gerlach, S., Haider, L., Zrzavy, T., Hametner, S., Mahad, D., Binder, C. J., Krumbholz, M., et al. (2013) · Brain · doi:10.1093/brain/awt110 · Cited by 311
Self-citationSchmied, M. C., Breitschopf, H., Gold, R., Zischler, H., Rothe, G., Wekerle, H., & Lassmann, H. (1993) · PubMed · Cited by 300
Self-citationInflammatory intrathecal profiles and cortical damage in multiple sclerosis
Magliozzi, R., Howell, O. W., Nicholas, R., Cruciani, C., Castellaro, M., Romualdi, C., Rossi, S., Pitteri, M., Benedetti, M. D., Gajofatto, A., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25197 · Cited by 298
Booss, J., Esiri, M. M., Tourtellotte, W. W., & Mason, D. Y. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90201-0 · Cited by 294
A comparison of the pathology of primary and secondary progressive multiple sclerosis
Revesz, T., Kidd, D., Thompson, A. J., Barnard, R. O., & McDonald, W. I. (1994) · Brain · doi:10.1093/brain/117.4.759 · Cited by 293
Extensive Hippocampal Demyelination in Multiple Sclerosis
Geurts, J. J. G., Bö, L., Roosendaal, S. D., Hazes, T., Daniëls, R., Barkhof, F., Witter, M. P., Huitinga, I., & van der Valk, P. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181461f54 · Cited by 287
Multiple Sclerosis: Immunopathology and Treatment Update
Dargahi, N., Katsara, M., Tselios, T., Androutsou, M.-E., De Courten, M., Matsoukas, J., & Apostolopoulos, V. (2017) · Brain Sciences · doi:10.3390/brainsci7070078 · Cited by 285
Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
Vercellino, M., Masera, S., Lorenzatti, M., Condello, C., Merola, A., Mattioda, A., Tribolo, A., Capello, E., Mancardi, G. L., Mutani, R., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a19a5a · Cited by 277
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Antel, J., Antel, S., Caramanos, Z., Arnold, D. L., & Kuhlmann, T. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0953-0 · Cited by 215
Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection
Steinbach, K., Vincenti, I., Kreutzfeldt, M., Page, N., Muschaweckh, A., Wagner, I., Drexler, I., Pinschewer, D., Korn, T., & Merkler, D. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151916 · Cited by 213
Imaging Cortical Lesions in Multiple Sclerosis With Ultra–High-Field Magnetic Resonance Imaging
Pitt, D., Boster, A., Pei, W., Wohleb, E., Jasne, A., Zachariah, C. R., Rammohan, K., Knopp, M. V., & Schmalbrock, P. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.148 · Cited by 210
Hohlfeld, R., Dornmair, K., Meinl, E., & Wekerle, H. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00334-8 · Cited by 197
Biomarkers in Multiple Sclerosis
Paul, A., Comabella, M., & Gandhi, R. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029058 · Cited by 183
Biomarkers in multiple sclerosis
Housley, W. J., Pitt, D., & Hafler, D. A. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.06.015 · Cited by 181
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
Lisak, R. P., Benjamins, J. A., Nedelkoska, L., Barger, J. L., Ragheb, S., Fan, B., Ouamara, N., Johnson, T. A., Rajasekharan, S., & Bar-Or, A. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.02.015 · Cited by 180
Hohlfeld, R., Dornmair, K., Meinl, E., & Wekerle, H. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00313-0 · Cited by 180
van Nierop, G. P., van Luijn, M. M., Michels, S. S., Melief, M.-J., Janssen, M., Langerak, A. W., Ouwendijk, W. J. D., Hintzen, R. Q., & Verjans, G. M. G. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1744-4 · Cited by 174
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
Mitrovič, M., Patsopoulos, N. A., Beecham, A. H., Dankowski, T., Goris, A., Dubois, B., D’hooghe, M. B., Lemmens, R., Van Damme, P., Søndergaard, H. B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.049 · Cited by 170
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics
Vidaurre, Ó. G., Haines, J. D., Sand, I. K., Adula, K. P., Huynh, J. L., McGraw, C. A., Zhang, F., Varghese, M., Sotirchos, E. S., Bhargava, P., et al. (2014) · Brain · doi:10.1093/brain/awu139 · Cited by 167
Dysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis
Hochmeister, S., Grundtner, R., Bauer, J., Engelhardt, B., Lyck, R., Gordon, G., Korosec, T., Kutzelnigg, A., Berger, J. J., Bradl, M., et al. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235119.52311.16 · Cited by 160
Self-citationOligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions
Mews, I., Bergmann, M., Bunkowski, S., Gullotta, F., & Brück, W. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400203 · Cited by 160
Immunological and neuropathological significance of the Virchow-Robin space
Esiri, M. M., & Gay, D. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90004-7 · Cited by 158
Schmierer, K., Parkes, H. G., So, P., An, S., Brandner, S., Ordidge, R. J., Yousry, T. A., & Miller, D. H. (2010) · Brain · doi:10.1093/brain/awp335 · Cited by 155
Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords
Androdias, G., Reynolds, R., Chanal, M., Ritleng, C., Confavreux, C., & Nataf, S. (2010) · Annals of Neurology · doi:10.1002/ana.22054 · Cited by 151
TISSUE CULTURE STUDIES OF DEMYELINATION*
Bornstein, M. B., & Appel, S. H. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb20212.x · Cited by 147
Jarius, S., Eichhorn, P., Franciotta, D. M., Petereit, H.-F., Akman‐Demir, G., Wick, M. W., & Wildemann, B. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8360-4 · Cited by 147
Trapp, B. D., Vignos, M., Dudman, J., Chang, A., Fisher, E., Staugaitis, S. M., Battapady, H., Mork, S., Ontaneda, D., Jones, S. E., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30245-x · Cited by 146
Han, S., Lin, Y. C., Wu, T., Salgado, A. D., Mexhitaj, I., Wuest, S. C., Romm, E., Ohayon, J. M., Goldbach‐Mansky, R. T., Vanderver, A. L., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302884 · Cited by 141
Cortical demyelination in multiple sclerosis: A substrate for cognitive deficits?
Kutzelnigg, A., & Lassmann, H. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.09.021 · Cited by 137
Self-citationB cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
Lisak, R. P., Nedelkoska, L., Benjamins, J. A., Schalk, D. L., Bealmear, B., Touil, H., Li, R., Muirhead, G., & Bar‐Or, A. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.05.004 · Cited by 135
CD8+ T-Cells as Immune Regulators of Multiple Sclerosis
Sinha, S., Boyden, A. W., Itani, F. R., Crawford, M. P., & Karandikar, N. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00619 · Cited by 126
Hypothalamic lesions in multiple sclerosis
Huitinga, I., De Groot, C. J. A., Van der Valk, P., Kamphorst, W., Tilders, F. J. H., & Swaab, D. F. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1208 · Cited by 120
Singh, S., Dallenga, T., Winkler, A., Roemer, S., Maruschak, B., Siebert, H., Brück, W., & Stadelmann, C. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0831-8 · Cited by 118
Howell, O. W., Schulz‐Trieglaff, E. K., Carassiti, D., Gentleman, S. M., Nicholas, R. S., Roncaroli, F., & Reynolds, R. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12199 · Cited by 115
Cognitive presentation of multiple sclerosis: evidence for a cortical variant
Zarei, M., Chandran, S., Compston, A., & Hodges, J. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.872 · Cited by 114
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis
Wang, Z., Sadovnick, A. D., Traboulsee, A. L., Ross, J. P., Bernales, C. Q., Encarnacion, M. J., Yee, I. M. L., de Lemos, M., Greenwood, T., Lee, J. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.039 · Cited by 112
Claes, N., Fraussen, J., Stinissen, P., Hupperts, R., & Somers, V. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00642 · Cited by 109
The Charcot Lecture | Beating MS: A story of B cells, with twists and turns
Hauser, S. L. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514561911 · Cited by 101
Hayashi, T., Morimoto, C., Burks, J. S., Kerr, C., & Hauser, S. L. (1988) · Annals of Neurology · doi:10.1002/ana.410240408 · Cited by 100
Storch, M. K., Bauer, J., Linington, C., Olsson, T. P., Weissert, R., & Lassmann, H. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000248547.13176.9d · Cited by 98
Self-citationBlauth, K., Soltys, J. N., Matschulat, A. M., Reiter, C. R., Ritchie, A. M., Baird, N. L., Bennett, J. L., & Owens, G. P. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1500-6 · Cited by 94
Natural history of primary progressive multiple sclerosis
Ebers, G. C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1025oa · Cited by 93
The relationship of age with the clinical phenotype in multiple sclerosis
Scalfari, A., Lederer, C., Däumer, M., Nicholas, R. S., Ebers, G. C., & Muraro, P. A. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516630396 · Cited by 92
Lehmann‐Horn, K., Häusser‐Kinzel, S., & Weber, M. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102048 · Cited by 86
Bielekova, B., Komori, M., Xu, Q., Reich, D. S., & Wu, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048370 · Cited by 81
Primary progressive multiple sclerosis: progress and challenges
Rice, C. M., Cottrell, D., Wilkins, A., & Scolding, N. J. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304140 · Cited by 78
Laule, C., Vavasour, I. M., Leung, E., Li, D. K., Kozlowski, P., Traboulsee, A. L., Oger, J., MacKay, A. L., & Moore, G. W. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458510384008 · Cited by 77
Stoessel, D., Stellmann, J., Willing, A., Behrens, B., Rosenkranz, S. C., Hodecker, S. C., Stürner, K. H., Reinhardt, S., Fleischer, S., Deuschle, C., et al. (2018) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2018.00226 · Cited by 76
Laule, C., Pavlova, V., Leung, E., Zhao, G., MacKay, A. L., Kozłowski, P., Traboulsee, A. L., Li, D. K. B., & Moore, G. R. W. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827bced3 · Cited by 75
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
Mañé-Martínez, M. A., Olsson, B., Bau, L., Matas, E., Cobo‐Calvo, Á., Andréasson, U., Blennow, K., Romero-Pinel, L., Martínez‐Yélamos, S., & Zetterberg, H. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.004 · Cited by 75
Moore, G. R. W., Laule, C., MacKay, A. L., Leung, E., Li, D. K. B., Zhao, G., Traboulsee, A. L., & Paty, D. W. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0002-z · Cited by 68
Laboratory Investigation of Cerebrospinal Fluid Proteins
Thompson, E. J., & Keir, G. (1990) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329002700503 · Cited by 68
Semaphorin4A and H‐ferritin utilize Tim‐1 on human oligodendrocytes: A novel neuro‐immune axis
Chiou, B., Lucassen, E. B., Sather, M. D., Kallianpur, A. R., & Connor, J. R. (2018) · Glia · doi:10.1002/glia.23313 · Cited by 68
Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis
Jia, X., Madireddy, L., Caillier, S. J., Santaniello, A., Esposito, F., Comı, G., Stüve, O., Zhou, Y., Taylor, B. V., Kilpatrick, T. J., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25263 · Cited by 68
Hametner, S., Bianco, A. D., Trattnig, S., & Lassmann, H. (2018) · Brain Pathology · doi:10.1111/bpa.12643 · Cited by 65
Self-citationApplying the 2017 McDonald diagnostic criteria for multiple sclerosis – Authors' reply
Thompson, A. J., Reingold, S. C., & Cohen, J. A. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30168-6 · Cited by 64
Molecular‐based diagnosis of multiple sclerosis and its progressive stage
Barbour, C. R., Kosa, P. F., Komori, M., Tanigawa, M., Masvekar, R., Wu, T., Johnson, K. R., Douvaras, P., Fossati, V., Herbst, R., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25083 · Cited by 60
Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
Abdelhak, A., Weber, M. S., & Tumani, H. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00234 · Cited by 58
Progressive Forms of Multiple Sclerosis
Zeydan, B., & Kantarci, O. H. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.08.006 · Cited by 57
Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study
Lily, O., Palace, J. A., & Vincent, A. C. (2004) · Brain · doi:10.1093/brain/awh031 · Cited by 55
Multiple sclerosis in sibling pairs: an analysis of 250 families
Chataway, J. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.6.757 · Cited by 53
Kuchling, J., Ramien, C., Bozin, I., Dörr, J., Harms, L., Rosche, B., Niendorf, T., Paul, F., Sinnecker, T., & Wuerfel, J. (2014) · Multiple Sclerosis · doi:10.1177/1352458514531084 · Cited by 50
Pan, G., Simpson, S., van der Mei, I. A. F., Charlesworth, J., Lucas, R. M., Ponsonby, A., Zhou, Y., Wu, F., & Taylor, B. V. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313722 · Cited by 48
CSF profile in primary progressive multiple sclerosis: Re-exploring the basics
Abdelhak, A., Hottenrott, T., Mayer, C., Hintereder, G., Zettl, U. K., Stich, O., & Tumani, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182647 · Cited by 48
Gross, R. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000561 · Cited by 47
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk
Antel, J. P., Ban, M., Baranzini, S. E., Barcellos, L. F., Barizzone, N., Beecham, A. H., Berge, T., Bernardinelli, L., Booth, D. R., Bos, S. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.052 · Cited by 30
Immunologic factors in primary progressive multiple sclerosis
Hohlfeld, R. (2004) · Multiple Sclerosis Journal · doi:10.1177/135245850401000104 · Cited by 24
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis
Sadovnick, A. D. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.05.002 · Cited by 20
Wurth, S., Kuenz, B., Bsteh, G., Ehling, R., Pauli, F. D., Hegen, H., Auer, M., Gredler, V., Deisenhammer, F., Reindl, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182462 · Cited by 20
Boyden, A. W., Brate, A. A., & Karandikar, N. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02336 · Cited by 15
Magnetic resonance imaging correlates of neuro‐axonal pathology in the MS spinal cord
Schmierer, K., & Miquel, M. E. (2018) · Brain Pathology · doi:10.1111/bpa.12648 · Cited by 13
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Treatment of Multiple Sclerosis: A Review
Hauser, S. L., & Cree, B. A. C. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.05.049 · Cited by 969
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 535
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
Faissner, S., Plemel, J. R., Gold, R., & Yong, V. W. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0035-2 · Cited by 459
Smouldering multiple sclerosis: the ‘real MS’
Giovannoni, G., Popescu, V., Wuerfel, J., Hellwig, K., Iacobaeus, E., Jensen, M. B., García-Domínguez, J. M., Sousa, L., De Rossi, N., Hupperts, R., et al. (2022) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211066751 · Cited by 271
Metadata
- Authors
- Lassmann, H.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-01-10
- Volume
- 9
- Pages
- 3116-3116
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2909270098
- Cited by
- 663
- References
- 118
- FWCI
- 45.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.